Centrifugal Versus Membrane‐Based Therapeutic Plasma Exchange in Pediatric Seronegative Neuroimmune Disorders: Neurologic Outcome and Age Specific Safety Profile
Therapeutic Apheresis and Dialysis · 2026-08 · 30 (4) · 489-501
DOI: 10.1002/1744-9987.70140 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Therapeutic Apheresis and Dialysis, online erschienen am 05.04.2026. Verfasst von Ebru Atike Ongun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Intensive Care, University of Health Sciences, Antalya Training and Research Hospital, Antalya, Turkey. Hauptthemen laut MEDLINE: Plasma Exchange, Nervous System Diseases. Die Arbeit nennt 39 Literaturangaben.
Abstract (Originalsprache)
Background
This study evaluated the effectiveness of therapeutic plasma exchange (TPE) modalities in seronegative pediatric neuroimmune disorders, focusing on acute therapy response, 6‐month neurological outcomes, and age‐stratified adverse events.
Methods
Retrospective observational cohort between 2018 and 2024. Neurological outcomes were assessed at five predetermined set points during 6 months.
Results
Forty‐six children underwent 304 TPE procedures in 49 sessions. Early favorable recovery were 84% for autoimmune‐encephalitis, 75% for CNS‐demyelinating‐disorders, 83.3% for Guillan‐Barre‐syndrome, 66.7% of Juvenile‐Myasthenia‐Gravis cases. Six–months neurological outcome showed similar recovery rates irrespective‐of‐TPE‐modality used (F[4169] = 0.53, p = 0.711; F[4470] = 0.69, p = 0.602 for CNS and PNS disorders). Adverse events occurred in 20.1% of TPE sessions, were largely age‐dependent rather than disease‐category or modality‐driven, with a 0.891‐fold reduction in the likelihood of AE occurrence for each‐year increment (OR = 0.891, 95% CI: 0.825–0.962, p = 0.003).
Conclusion
Centrifugal and membrane‐based TPE are associated with good neurological recovery in seronegative pediatric neuroimmune disorders. Patient age, rather than apheresis modality or disease subtype, has emerged as the primary determinant of the adverse event profile.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Intensive Care, University of Health Sciences, Antalya Training and Research Hospital, Antalya, Turkey.
- Department of Pediatric Hematology and Oncology, University of Health Sciences, Antalya Training and Research Hospital, Antalya, Turkey.
- Department of Pediatric Neurology, University of Health Sciences, Antalya Training and Research Hospital, Antalya, Turkey.
- Department of Hematology, University of Health Sciences, Antalya Training and Research Hospital, Antalya, Turkey.
ORCID-Profile: Ebru Atike Ongun, Sultan Aydın, Hasan Serdar Kıhtır, Erdem Çebişli, Muhammed Gultekin Kutluk, Duygu Güner Özcanyüz, Ayse Oz, Volkan Karakuş
Zitieren
APA
Ongun, E. A., Aydın, S., Kıhtır, H. S., Çebişli, E., Kutluk, M. G., Özcanyüz, D. G., Oz, A., & Karakuş, V. (2026). Centrifugal Versus Membrane‐Based Therapeutic Plasma Exchange in Pediatric Seronegative Neuroimmune Disorders: Neurologic Outcome and Age Specific Safety Profile. Therapeutic Apheresis and Dialysis, 30(4), 489-501. https://doi.org/10.1002/1744-9987.70140
Vancouver
Ongun EA, Aydın S, Kıhtır HS, Çebişli E, Kutluk MG, Özcanyüz DG, et al. Centrifugal Versus Membrane‐Based Therapeutic Plasma Exchange in Pediatric Seronegative Neuroimmune Disorders: Neurologic Outcome and Age Specific Safety Profile. Therapeutic Apheresis and Dialysis. 2026;30(4):489-501. doi:10.1002/1744-9987.70140
BibTeX
@article{Ongun2026,
author = {Ongun, Ebru Atike and Aydın, Sultan and Kıhtır, Hasan Serdar and Çebişli, Erdem and Kutluk, Muhammed Gultekin and Özcanyüz, Duygu Güner and Oz, Ayse and Karakuş, Volkan},
title = {Centrifugal Versus Membrane‐Based Therapeutic Plasma Exchange in Pediatric Seronegative Neuroimmune Disorders: Neurologic Outcome and Age Specific Safety Profile},
journal = {Therapeutic Apheresis and Dialysis},
year = {2026},
volume = {30},
number = {4},
pages = {489--501},
doi = {10.1002/1744-9987.70140}
}
EUVIMED